Literature DB >> 15016848

Cleavage of eukaryotic translation initiation factor 4GII within foot-and-mouth disease virus-infected cells: identification of the L-protease cleavage site in vitro.

Alessandra Gradi1, Nicole Foeger, Rebecca Strong, Yuri V Svitkin, Nahum Sonenberg, Tim Skern, Graham J Belsham.   

Abstract

Foot-and-mouth disease virus (FMDV) induces a very rapid inhibition of host cell protein synthesis within infected cells. This is accompanied by the cleavage of the eukaryotic translation initiation factor 4GI (eIF4GI). The cleavage of the related protein eIF4GII has now been analyzed. Within FMDV-infected cells, cleavage of eIF4GI and eIF4GII occurs with similar kinetics. Cleavage of eIF4GII is induced in cells and in cell extracts by the FMDV leader protease (L(pro)) alone, generating cleavage products similar to those induced by enterovirus and rhinovirus 2A protease (2A(pro)). By the use of a fusion protein containing residues 445 to 744 of human eIF4GII, it was demonstrated that the FMDV L(pro) specifically cleaves this protein between residues G700 and S701, immediately adjacent to the site (V699/G700) cleaved by rhinovirus 2A(pro) in vitro. The G700/S701 cleavage site does not correspond, by amino acid sequence alignment, to that cleaved in eIF4GI by the FMDV L(pro) in vitro. Knowledge of the cleavage sites and the three-dimensional structures of the FMDV L(pro) and rhinovirus 2A(pro) enabled mutant forms of the eIF4GII sequence to be generated that are differentially resistant to either one of these proteases. These results confirmed the specificity of each protease and showed that the mutant forms of the fusion protein substrate retained their correct sensitivity to other proteases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15016848      PMCID: PMC371048          DOI: 10.1128/jvi.78.7.3271-3278.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.

Authors:  T R Fuerst; E G Niles; F W Studier; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

2.  Recognition of picornavirus internal ribosome entry sites within cells; influence of cellular and viral proteins.

Authors:  L O Roberts; R A Seamons; G J Belsham
Journal:  RNA       Date:  1998-05       Impact factor: 4.942

3.  All foot and mouth disease virus serotypes initiate protein synthesis at two separate AUGs.

Authors:  D V Sangar; S E Newton; D J Rowlands; B E Clarke
Journal:  Nucleic Acids Res       Date:  1987-04-24       Impact factor: 16.971

4.  Proteolysis of the p220 component of the cap-binding protein complex is not sufficient for complete inhibition of host cell protein synthesis after poliovirus infection.

Authors:  A M Bonneau; N Sonenberg
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

5.  Poliovirus proteinase 2A induces cleavage of eucaryotic initiation factor 4F polypeptide p220.

Authors:  H G Kräusslich; M J Nicklin; H Toyoda; D Etchison; E Wimmer
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

6.  A novel functional human eukaryotic translation initiation factor 4G.

Authors:  A Gradi; H Imataka; Y V Svitkin; E Rom; B Raught; S Morino; N Sonenberg
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

7.  Human rhinovirus 2A proteinase cleavage sites in eukaryotic initiation factors (eIF) 4GI and eIF4GII are different.

Authors:  Alessandra Gradi; Yuri V Svitkin; Wolfgang Sommergruber; Hiroaki Imataka; Shigenobu Morino; Tim Skern; Nahum Sonenberg
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

8.  Leader protein of foot-and-mouth disease virus is required for cleavage of the p220 component of the cap-binding protein complex.

Authors:  M A Devaney; V N Vakharia; R E Lloyd; E Ehrenfeld; M J Grubman
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

9.  Relationship of p220 cleavage during picornavirus infection to 2A proteinase sequencing.

Authors:  R E Lloyd; M J Grubman; E Ehrenfeld
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

10.  Generation of multiple isoforms of eukaryotic translation initiation factor 4GI by use of alternate translation initiation codons.

Authors:  Marshall P Byrd; Miguel Zamora; Richard E Lloyd
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

View more
  40 in total

1.  Selective Removal of FG Repeat Domains from the Nuclear Pore Complex by Enterovirus 2A(pro).

Authors:  Nogi Park; Nicholas J Schweers; Kurt E Gustin
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

2.  Complete genome analysis of three novel picornaviruses from diverse bat species.

Authors:  Susanna K P Lau; Patrick C Y Woo; Kenneth K Y Lai; Yi Huang; Cyril C Y Yip; Chung-Tong Shek; Paul Lee; Carol S F Lam; Kwok-Hung Chan; Kwok-Yung Yuen
Journal:  J Virol       Date:  2011-06-22       Impact factor: 5.103

3.  Specific cleavage of the nuclear pore complex protein Nup62 by a viral protease.

Authors:  Nogi Park; Tim Skern; Kurt E Gustin
Journal:  J Biol Chem       Date:  2010-07-09       Impact factor: 5.157

4.  Increased replicative fitness can lead to decreased drug sensitivity of hepatitis C virus.

Authors:  Julie Sheldon; Nathan M Beach; Elena Moreno; Isabel Gallego; David Piñeiro; Encarnación Martínez-Salas; Josep Gregori; Josep Quer; Juan Ignacio Esteban; Charles M Rice; Esteban Domingo; Celia Perales
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

5.  Identification of a novel feline picornavirus from the domestic cat.

Authors:  Susanna K P Lau; Patrick C Y Woo; Cyril C Y Yip; Garnet K Y Choi; Ying Wu; Ru Bai; Rachel Y Y Fan; Kenneth K Y Lai; Kwok-Hung Chan; Kwok-Yung Yuen
Journal:  J Virol       Date:  2011-10-26       Impact factor: 5.103

6.  Influenza virus polymerase confers independence of the cellular cap-binding factor eIF4E for viral mRNA translation.

Authors:  Emilio Yángüez; Paloma Rodriguez; Ian Goodfellow; Amelia Nieto
Journal:  Virology       Date:  2011-11-23       Impact factor: 3.616

7.  A Naturally Occurring Recombinant Enterovirus Expresses a Torovirus Deubiquitinase.

Authors:  Pengcheng Shang; Saurav Misra; Ben Hause; Ying Fang
Journal:  J Virol       Date:  2017-06-26       Impact factor: 5.103

8.  The spliceosome factor SART1 exerts its anti-HCV action through mRNA splicing.

Authors:  Wenyu Lin; Chuanlong Zhu; Jian Hong; Lei Zhao; Nikolaus Jilg; Dahlene N Fusco; Esperance A Schaefer; Cynthia Brisac; Xiao Liu; Lee F Peng; Qikai Xu; Raymond T Chung
Journal:  J Hepatol       Date:  2014-12-03       Impact factor: 25.083

9.  Residue L143 of the foot-and-mouth disease virus leader proteinase is a determinant of cleavage specificity.

Authors:  Christina Mayer; David Neubauer; Aloysius T Nchinda; Regina Cencic; Katja Trompf; Tim Skern
Journal:  J Virol       Date:  2008-02-27       Impact factor: 5.103

10.  HIV- 1 protease inhibits Cap- and poly(A)-dependent translation upon eIF4GI and PABP cleavage.

Authors:  Alfredo Castelló; David Franco; Pablo Moral-López; Juan J Berlanga; Enrique Alvarez; Eckard Wimmer; Luis Carrasco
Journal:  PLoS One       Date:  2009-11-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.